174 related articles for article (PubMed ID: 30783117)
1. Fasciola hepatica GST downregulates NF-κB pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model.
Aguayo V; Valdés Fernandez BN; Rodríguez-Valentín M; Ruiz-Jiménez C; Ramos-Benítez MJ; Méndez LB; Espino AM
Sci Rep; 2019 Feb; 9(1):2275. PubMed ID: 30783117
[TBL] [Abstract][Full Text] [Related]
2.
Valdes-Fernandez BN; Ruiz-Jimenez C; Armina-Rodriguez A; Mendez LB; Espino AM
bioRxiv; 2023 Aug; ():. PubMed ID: 37609327
[TBL] [Abstract][Full Text] [Related]
3. Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.
Martin I; Cabán-Hernández K; Figueroa-Santiago O; Espino AM
J Immunol; 2015 Apr; 194(8):3924-36. PubMed ID: 25780044
[TBL] [Abstract][Full Text] [Related]
4. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function.
Hamilton CM; Dowling DJ; Loscher CE; Morphew RM; Brophy PM; O'Neill SM
Infect Immun; 2009 Jun; 77(6):2488-98. PubMed ID: 19332532
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Fasciola hepatica Fatty Acid Binding Protein as a Novel Anti-Inflammatory Biotherapeutic Drug in an Acute Gram-Negative Nonhuman Primate Sepsis Model.
Rosado-Franco JJ; Armina-Rodriguez A; Marzan-Rivera N; Burgos AG; Spiliopoulos N; Dorta-Estremera SM; Mendez LB; Espino AM
Microbiol Spectr; 2021 Dec; 9(3):e0191021. PubMed ID: 34937173
[TBL] [Abstract][Full Text] [Related]
6. The regulatory roles of Fasciola hepatica GSTO1 protein in inflammatory cytokine expression and apoptosis in murine macrophages.
Xifeng W; Jiahua Z; Ningxing L; Guowu Z; Yunxia S; Xuepeng C; Jun Q; Xianzhu X; Qingling M
Acta Trop; 2023 Sep; 245():106977. PubMed ID: 37399980
[TBL] [Abstract][Full Text] [Related]
7. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock.
Ramos-Benitez MJ; Ruiz-Jimenez C; Rosado-Franco JJ; Ramos-Pérez WD; Mendez LB; Osuna A; Espino AM
mSphere; 2018 Dec; 3(6):. PubMed ID: 30567900
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands.
Ramos-Benítez MJ; Ruiz-Jiménez C; Aguayo V; Espino AM
Sci Rep; 2017 Jul; 7(1):5455. PubMed ID: 28710478
[TBL] [Abstract][Full Text] [Related]
9. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses.
Dowling DJ; Hamilton CM; Donnelly S; La Course J; Brophy PM; Dalton J; O'Neill SM
Infect Immun; 2010 Feb; 78(2):793-801. PubMed ID: 19917714
[TBL] [Abstract][Full Text] [Related]
10. A mucin-like peptide from Fasciola hepatica instructs dendritic cells with parasite specific Th1-polarizing activity.
Noya V; Brossard N; Rodríguez E; Dergan-Dylon LS; Carmona C; Rabinovich GA; Freire T
Sci Rep; 2017 Jan; 7():40615. PubMed ID: 28079156
[TBL] [Abstract][Full Text] [Related]
11. Potential role for excretory-secretory forms of glutathione-S-transferase (GST) in Fasciola hepatica.
Cervi L; Rossi G; Masih DT
Parasitology; 1999 Dec; 119 ( Pt 6)():627-33. PubMed ID: 10633925
[TBL] [Abstract][Full Text] [Related]
12. Fasciola hepatica tegumental coat impairs mast cells' ability to drive Th1 immune responses.
Vukman KV; Adams PN; Metz M; Maurer M; O'Neill SM
J Immunol; 2013 Mar; 190(6):2873-9. PubMed ID: 23418624
[TBL] [Abstract][Full Text] [Related]
13.
Valdes-Fernandez BN; Ruiz-Jimenez C; Armina-Rodriguez A; Mendez LB; Espino AM
Microbiol Spectr; 2024 Jan; 12(1):e0347523. PubMed ID: 38018982
[TBL] [Abstract][Full Text] [Related]
14. Fasciola hepatica: the therapeutic potential of a worm secretome.
Robinson MW; Dalton JP; O'Brien BA; Donnelly S
Int J Parasitol; 2013 Mar; 43(3-4):283-91. PubMed ID: 23220126
[TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica tegumental coat antigen suppresses MAPK signalling in dendritic cells and up-regulates the expression of SOCS3.
Vukman KV; Adams PN; O'Neill SM
Parasite Immunol; 2013 Jul; 35(7-8):234-8. PubMed ID: 23495757
[TBL] [Abstract][Full Text] [Related]
16. Fasciola hepatica: host responders and nonresponders to parasite glutathione S-transferase.
Hillyer GV; Soler de Galanes M; Battisti G
Exp Parasitol; 1992 Sep; 75(2):176-86. PubMed ID: 1516666
[TBL] [Abstract][Full Text] [Related]
17. Production of Monoclonal Antibody Against Excretory-Secretory Antigen of Fasciola hepatica and Evaluation of Its Efficacy in the Diagnosis of Fascioliasis.
Abdolahi Khabisi S; Sarkari B; Moshfe A; Jalali S
Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):8-14. PubMed ID: 28186433
[TBL] [Abstract][Full Text] [Related]
18. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effect of a Nuphar lutea partially purified leaf extract in murine models of septic shock.
Ozer J; Levi T; Golan-Goldhirsh A; Gopas J
J Ethnopharmacol; 2015 Feb; 161():86-91. PubMed ID: 25490314
[TBL] [Abstract][Full Text] [Related]
20. Glycans from Fasciola hepatica Modulate the Host Immune Response and TLR-Induced Maturation of Dendritic Cells.
Rodríguez E; Noya V; Cervi L; Chiribao ML; Brossard N; Chiale C; Carmona C; Giacomini C; Freire T
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004234. PubMed ID: 26720149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
